Activity Monitoring Assessment of Opiate Withdrawal - 4

Opioid-Related Disorders Clinical Trial

Official title:

Activity Monitoring Assessment of Opiate Withdrawal

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00000335
• Other study ID #: NIDA-3-0009-4
• Secondary ID: Y01-3-0009-4
• Status: Completed
• Phase: Phase 2
• First received: September 20, 1999
• Last updated: January 30, 2017
• Start date: September 30, 1995
• Est. completion date: May 20, 1996

Study information

• Verified date: December 2002
• Source: National Institute on Drug Abuse (NIDA)
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine if hyperactivity accompanies abrupt opiate withdrawal in heroin addicts, to determine if computerized solid state activity monitors are capable of quantifying hyperactivity, and to quantify the physical and affective symptoms occurring during abrupt withdrawal in heroin addicts and morphine's capacity to alleviate these symptoms.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 0
• Est. completion date: May 20, 1996
• Est. primary completion date: March 20, 1996
• Accepts healthy volunteers: No
• Gender: Male
• Age group: 21 Years to 55 Years
• Eligibility: Please contact site for information.

Related Conditions & MeSH terms

• Opioid-Related Disorders

Intervention

Drug:
• Morphine

Locations

Country	Name	City	State
United States	Washington DC VA	Washington	District of Columbia

Sponsors (2)

Lead Sponsor	Collaborator
National Institute on Drug Abuse (NIDA)	Washington D.C. Veterans Affairs Medical Center

Country where clinical trial is conducted

United States, 

References & Publications (1)

1996 CPDD, NIDA Research Monograph

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Depression
Primary	Anxiety
Primary	Withdrawal severity
Primary	Activity
Primary	Opiate secondary withdrawal